Inovio Pharmaceuticals
INO
#9200
Rank
โ‚ฌ91.93 M
Marketcap
1,34ย โ‚ฌ
Share price
-3.11%
Change (1 day)
-30.76%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2025 (TTM): -2,53ย โ‚ฌ

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -2,47ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of -3,39ย โ‚ฌ an increase over its 2023 EPS that were of -5,22ย โ‚ฌ.

EPS history for Inovio Pharmaceuticals from 1999 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-2,53ย โ‚ฌ-25.35%
2024-3,39ย โ‚ฌ-35.14%
2023-5,22ย โ‚ฌ-56.62%
2022-12,04ย โ‚ฌ-19.54%
2021-14,97ย โ‚ฌ35.9%
2020-11,01ย โ‚ฌ-11.57%
2019-12,46ย โ‚ฌ15.24%
2018-10,81ย โ‚ฌ-2.78%
2017-11,12ย โ‚ฌ6.93%
2016-10,40ย โ‚ฌ134.88%
2015-4,43ย โ‚ฌ-29.51%
2014-6,28ย โ‚ฌ-57.34%
2013-14,72ย โ‚ฌ146.55%
2012-5,97ย โ‚ฌ20.83%
2011-4,94ย โ‚ฌ-29.41%
2010-7,00ย โ‚ฌ-48.48%
2009-13,59ย โ‚ฌ10%
2008-12,35ย โ‚ฌ11.11%
2007-11,12ย โ‚ฌ-41.3%
2006-18,94ย โ‚ฌ-66.91%
2005-57,23ย โ‚ฌ110.61%
2004-27,17ย โ‚ฌ-61.63%
2003-70,82ย โ‚ฌ186.67%
2002-24,70ย โ‚ฌ
2001N/A-100%
2000-19,76ย โ‚ฌ-62.98%
1999-53,39ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
1,48ย โ‚ฌ-159.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
8,95ย โ‚ฌ-462.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-1,07ย โ‚ฌ-56.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
6,31ย โ‚ฌ-355.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
6,51ย โ‚ฌ-363.67%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
3,08ย โ‚ฌ-224.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
5,59ย โ‚ฌ-326.39%๐Ÿ‡บ๐Ÿ‡ธ USA